Suppr超能文献

欧洲不明肝脏疾病成年患者中肝纤维化的高患病率:一项基于人群的研究。

High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study.

机构信息

Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigació en Atenció, Primària Jordi Gol, Mataró, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain.

Unitat de Suport a la Recerca Metropolitana Nord, Institut Universitari d'Investigació en Atenció, Primària Jordi Gol, Mataró, Barcelona, Spain.

出版信息

Clin Gastroenterol Hepatol. 2018 Jul;16(7):1138-1145.e5. doi: 10.1016/j.cgh.2017.12.048. Epub 2018 Feb 13.

Abstract

BACKGROUND & AIMS: Liver fibrosis is the main determinant of long-term outcome in chronic liver diseases. Little is known about the prevalence of liver fibrosis in the general population. The aim of the study was to investigate the prevalence of liver fibrosis in the general adult population with unknown liver disease.

METHODS

This was a population-based, cross-sectional study performed in the Barcelona metropolitan area. Subjects aged 18 to 75 years old were identified randomly from citizens included in the primary health care registry. Of 4866 subjects invited, 3076 participated (63.2%). Liver fibrosis was estimated by measuring liver stiffness (LS) with transient elastography (TE). Liver histology was assessed in 92 subjects with increased LS.

RESULTS

Prevalence estimates of increased LS (≥6.8, ≥8.0, and ≥9.0 kPa) were 9.0%, 5.8%, and 3.6%, respectively. The etiology of liver disease was mainly nonalcoholic fatty liver disease (NAFLD), followed by alcohol risk consumption (consumption of ≥21 standard drinking units/wk in men and ≥14 standard drinking units/wk in women). Factors independently associated with increased LS were male sex, abdominal obesity, type 2 diabetes, serum glucose, high-density lipoprotein, and triglyceride levels. Subjects without risk factors for NAFLD or without alcohol risk consumption had a very low prevalence of increased LS. The best cut-off value of LS for significant liver fibrosis (F2-F4) was 9.2 kPa, with high sensitivity and specificity. TE was more accurate than alanine aminotransferase, NAFLD fibrosis score, or Fibrosis 4. An algorithm for screening for liver fibrosis using TE in the community setting is proposed.

CONCLUSIONS

These findings show a high prevalence of silent liver disease with advanced fibrosis mainly related to NAFLD in adult European subjects without known liver disease. An LS value less than 9.2 kPa predicts the absence of significant liver fibrosis with high accuracy and could be used for screening purposes.

摘要

背景与目的

肝纤维化是慢性肝病长期预后的主要决定因素。对于一般人群中肝纤维化的流行情况知之甚少。本研究旨在调查一般成年人群中未知肝脏疾病的肝纤维化患病率。

方法

这是一项在巴塞罗那大都市区进行的基于人群的横断面研究。从初级保健登记册中纳入的公民中随机选择年龄在 18 至 75 岁之间的受试者。在邀请的 4866 名受试者中,有 3076 名(63.2%)参加了研究。使用瞬时弹性成像(TE)测量肝硬度(LS)来估计肝纤维化。在 LS 升高的 92 名受试者中评估肝组织学。

结果

LS 升高(≥6.8、≥8.0 和≥9.0kPa)的患病率估计值分别为 9.0%、5.8%和 3.6%。肝脏疾病的病因主要是非酒精性脂肪性肝病(NAFLD),其次是酒精风险消费(男性每周≥21 个标准饮酒单位,女性每周≥14 个标准饮酒单位)。与 LS 升高独立相关的因素是男性、腹部肥胖、2 型糖尿病、血清葡萄糖、高密度脂蛋白和甘油三酯水平。没有 NAFLD 风险因素或没有酒精风险消费的受试者 LS 升高的患病率非常低。LS 用于诊断显著肝纤维化(F2-F4)的最佳截断值为 9.2kPa,具有较高的敏感性和特异性。TE 比丙氨酸氨基转移酶、NAFLD 纤维化评分或 Fibrosis 4 更准确。提出了一种使用 TE 在社区环境中筛查肝纤维化的算法。

结论

这些发现表明,在没有已知肝脏疾病的欧洲成年人群中,一种主要与非酒精性脂肪性肝病相关的隐匿性肝病,其肝纤维化程度较高。LS 值小于 9.2kPa 可准确预测无显著肝纤维化,可用于筛查目的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验